Net Loss Per Share (Details 1) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2021 |
Jun. 30, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
|
Net Loss Per Share | ||||
Warrants outstanding | 45,577 | 70,361 | 45,577 | 70,361 |
Stock options outstanding | 563,734 | 508,762 | 563,734 | 508,762 |
RSUs outstanding | $ 243,800 | $ 0 | $ 243,800 | $ 0 |
Series A convertible preferred stock to common shares | 80,235 | 79,744 | 80,235 | 79,744 |
Series B convertible preferred stock to common shares | $ 281,690 | $ 262,805 | $ 281,690 | $ 262,805 |
Outstanding securities ,Total | 1,215,036 | 921,672 | 1,215,036 | 921,672 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|